Michael Heneka is a board-certified neurologist and clinician-scientist with a >25-year track record in studying neurodegenerative disease at the experimental, preclinical and clinical level. He has a long-standing interest in immunology and neuroscience. Although the main focus of his work relates to dementia and Alzheimer’s disease, he has also been working on Amyotrophic Lateral Sclerosis and Parkinson’s disease. To date he has published more than 300 peer-reviewed manuscripts. At the clinical level, he has established a neurodegenerative outpatient unit at both the University of Münster and the University of Bonn. From 2016 to 2021, he led the department of neurodegenerative disease and geriatric psychiatry in Bonn. Since 2012, he has been an adjunct professor of medicine and infectious diseases at the UMass Chan Medical School, and in January 2022 he became the director of the Luxembourg Centre of Systems Biomedicine at the University of Luxembourg.
Associated Grants
-
Evaluating the Therapeutic Potential of GPNMB in Preclinical Alpha-synuclein Models of Parkinson’s Disease
2025